The consequences of growth hormone deficiency in adulthood, and the effects of growth hormone replacement

Schweizerische Medizinische Wochenschrift

Volumn 127, Issue 35, 1997, Pages 1440-1449

  Christ, E R ^a   Carroll, P V ^a   Russell Jones, D L ^a   Sonksen P H ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE;

ADIPOSE TISSUE; ADULT; BODY COMPOSITION; BONE MASS; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERANCE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; OBESITY; QUALITY OF LIFE; REVIEW;

ADULT; BODY COMPOSITION; BODY HEIGHT; DWARFISM, PITUITARY; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; QUALITY OF LIFE;

EID: 0030777287     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Raben MS: Clinical use of human growth hormone. N Engl J Med 1962; 266: 82-86.
2. De Boer H, Blok GJ, van der Veen VA: Clinical aspects of growth hormone deficiency in adults. Endocr Rev 1995; 16: 63-86.
3. Salomon F, Cuneo RD, Hesp R, Sönksen PH: The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989; 321: 1797-1803.
4. Bengtsson BA, Eden S, Lonn L, Kvist H, Stokland A et al.: Treatment of adults with growth hormone deficiency with recombinant human GH. J Clin Endocrinol Metab 1993; 76: 309-317.
5. Binnerts A, Swart GR, Wilson JHP, Hoogerbrugge N, Pois HAP et al.: The effect of growth hormone administration in growth hormone-deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as body composition. Clin Endocrinol 1992; 37: 79-87.
6. Chong PKK, Jung RT, Scrimgeour CM, Rennie MJ, Paterson CR: Energy expenditure and body composition in growth hormone-deficient adults on exogenous growth hormone. Clin Endocrinol 1994; 40: 103-110.
7. Hoffman DM, O'Sullivan AJ, Freund J, Ho KK: Adults with growth hormone deficiency have abnormal body composition but normal energy metabolism. J Clin Endocrinol Metab 1995; 80: 72-77.
8. Beshyah SA, Freemantle C, Thomas E, Rutherford O, Page B et al.: Abnormal body composition and reduced bone mass in growth hormone-deficient hypopituitary adults. Clin Endocrinol 1995; 42: 179-189.
9. Rosen T, Bosaeus I, Tolli J, Lindstedt G, Bengtsson BA: Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency. Clin Endocrinol 1993; 38: 63-71.
10. Amato G, Carella C, Fazio S, La Montagna G, Cittadini A et al.: Body composition, bone metabolism and heart structure and function in growth hormone-deficient adults before and after GH replacement therapy at low doses. J Clin Endocrinol Metab 1993; 77: 1671-1676.
11. Snel YE, Doerga ME, Brummer RM, Zelissen PM, Koppeschaar HP: Magnetic resonance imaging-assessed adipose tissue and serum lipid and insulin concentrations in growth hormone-deficient adults. Effect of growth hormone replacement. Arterioscler Thromb Vase Biol 1995; 15: 1543-1548.
12. Moller J, Frandsen E, Fisker S, Jorgensen JOL, Christiansen JS: Decreased plasma and extracellular volume in growth hormone-deficient adults and the acute and prolonged effects of GH administration: a controlled experimental study. Clin Endocrinol 1996; 44: 533-539.
13. Christ E, Cummings MH, Westwood NB, Sawyer BM, Pearson TC et al.: The importance of growth hormone in the regulation of erythropoiesis, red cell mass and plasma volume in adults with growth hormone deficiency. J Clin Endocrinol Metab [in Press].
14. Johansson G, Rosen T, Lindstedt G, Bosaeus I, Bengtsson BA: Effect of 2 years of growth hormone treatment on body composition and cardiovascular risk factors in adults with growth hormone deficiency. J Clin Endocrinol Metab 1996; 4 (Suppl A): 3-12.
15. Jorgensen JOL, Thuesen L, Muller J et al.: Three years of growth hormone treatment in growth hormone-deficient adults: near normalization of body composition and physical performance. Eur J Endocrinol 1994; 130: 224-228.
16. Jorgensen JOL, Pedersen SA, Thuesen L et al.: Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989/I: 1221-1225.
17. Beshyah SA, Freemantle C, Shahi M, Anyaoku V, Merson S et al:. Replacement therapy with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults. Clin Endocrinol 1995; 42: 73-81.
18. Attanasio AF, Lamberts SWJ, Matranga AMC, Birkett MA, Bates PC et al.: Adult growth hormone-deficient patients demonstrate heterogenity between childhood onset and adult onset before and during human GH treatment. J Clin Endocrinol Metab 1997; 82: 82-88.
19. Hoffman DM, Crampton L, Sernia C, Nguyen TV, Ho KKY: Short-term growth hormone (GH) treatment of GH-deficient adults increases body sodium and extracellular water, but not blood pressure. J Clin Endocrinol Metab 1996; 81: 1123-1128.
20. O'Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes SJ, Adams JE, Shalet SM: Increased bone density after recombinant human growth hormone therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab 1993; 76: 1344-1348.
21. Kaufman JM, Taelman P, Vermeulen A, Vandeweghe M: Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary insufficiencies of childhood onset. J Clin Endocrinol Metab 1992; 74: 118-123.
22. Holmes SJ, Economou G, Whitehouse RW, Adams JE, Shalet SM: Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab 1994; 78: 669-674.
23. Degerblad M, Bengtsson BA, Bramnert M, Johnell O, Manhem P et al.: Reduced bone mineral density in adults with growth hormone deficiency: increased bone turnover during 12 months of GH substitution. Eur J Endocrinol 1995; 133: 180-188.
24. Wüster CHR, Slenczka E, Ziegler R: Increased prevalence of osteoporosis and arteriosclerosis in patients with conventionally substituted pituitary insufficiency: Is there a need for additional growth hormone substitution? Klin Wochenschr 1991; 69: 769-773.
25. Rosen T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G, Lindstedt G et al.: Increased fracture rate in adults with growth hormone deficiency. J Clin Endocrinol Metab 1996; 3 (Suppl A): 121.
26. Vandeweghe M, Taelman P, Kaufman JM: Short- and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin Endocrinol 1993; 39: 409-415.
27. Kann P, Piepkorn B, Schehler B, Piepenburg R, Lotz J et al.: Replacement therapy with recombinant human growth hormone in GH-deficient adults. Effects on bone metabolism and bone mineral density in a 2-year prospective study. J Clin Endocrinol Metab 1995; 2 (Suppl B): 103-110.
28. Beshyah SA, Thomas E, Kyd P, Sharp P, Fairney A, Johnston DG: The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism. Clin Endocrinol 1994; 40: 383-391.
29. Beshyah SA, Kyd P, Thomas E, Fairney A, Johnston DG: The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults. Clin Endocrinol 1995; 42: 249-254.
30. Holmes SJ, Whitehouse RW, Swindell R, Economou G, Adams JE, Shalet SM: Effect of growth hormone replacement on bone mass in adults with adult-onset growth hormone deficiency. Clin Endocrinol 1995; 42: 627-633.
31. Cuneo RC, Salomon F, Wiles CM, Hesp R, Sönksen PH: Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance. J Appl Physiol 1991; 70: 695-700.
32. Cuneo RC, Salomon F, Wiles CM, Sönksen PH: Skeletal muscle performance in adults with growth hormone deficiency. Hormone Research 1990; 33 (Suppl 4): 55-60.
33. Cuneo RC, Salomon F, Wiles CM, Hesp R, Sönksen PH: Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength. J Appl Physiol 1991; 70: 688-694.
34. Degerblad M, Almkvist O, Grunditz R, Hall K, Kaijser L et al.: Physical and psychological capabilities during substitution therapy with recombinant growth hormone in adults with growth hormone deficiency. Acta Endocrinologica 1990; 123: 185-193.
35. Rosen T, Bengtsson B-Å: Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990; 336: 285-288.
36. Erfurth EM, Buelow B, Mikozy Z, Nordstroem CH, Hagmar L: Increased cardiovascular mortality in patients with hypopituitarism. J Clin Endocrinol Metab 1996; 3 (Suppl A):121.
37. Rosen T, Eden S, Larson G, Wilhelmsen L, Bengtsson B-Å: Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol 1993; 129: 195-200.
38. Markussis V, Beshyah SA, Fisher C, Sharp P, Nicolaides AN, Johnston DG: Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet 1992; 340: 1188-1192.
39. Lehmann ED, Hopkins KD, Weissberger AJ, Gosling RG, Sönksen PH: Aortic distensibility in growth hormone-deficient adults. Lancet 1993; 341: 309.
40. Caidahl K, Edén S, Bengtsson B-Å: Cardiovascular and renal effects of growth hormone. Clin Endocrinol 1994; 40: 393-400.
41. Thuesen L, Jorgensen JOL, Muller JR, Kristensen BO, Skakkebaek NE et al.: Short- and long-term cardiovascular effect of growth hormone therapy in growth hormone-deficient adults. Clin Endocrinol 1994; 41: 615-620.
42. Cuocolo A, Nicolai E, Colao A, Longobardi S, Cardei S et al.: Improved left ventricular function after growth hormone replacement in patients with hypopituitarism: assessment with radionuclide angiography. Eur J Nucl Med 1996; 23: 390-394.
43. Salomon F, Cuneo RC, Umpleby AM, Sönksen PH: Interactions of body fat and muscle mass with substrate concentrations and fasting insulin levels in adults with growth hormone deficiency. Clin Sci 1994; 87: 201-206.
44. Jorgensen JOL, Pedersen SA, Laurberg P, Weeke J, Skakkebaek NE et al.: Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism. J Clin Endocrinol Metab 1989; 69: 1127-1132.
45. Hussain MA, Schmitz O, Mengel A, Glatz Y, Christiansen JS et al.: Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans. J Clin Invest 1994; 94: 1126-1133.
46. Russell-Jones DL, Weissberger AJ, Bowes SB, Kelly JM, Thomason M et al.: The effects of growth hormone on protein metabolism in adult growth hormone-deficient patients. Clin Endocrinol 1993; 38: 427-431.
47. O'Neal DN, Kalfas A, Dunning PL, Christopher MJ, Sawyer SD et al.: The effect of 3 months of recombinant human growth hormone (GH) therapy on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults: a minimal model analysis. J Clin Endocrinol Metab 1994; 79: 975-983.
48. Hew FL, Koschmann M, Christopher M, Rantzau C, Vaag A et al.: Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activity. J Clin Endocrinol Metab 1996; 81: 555-564.
49. Fowelin J, Attvall S, Lager I, Bengtsson BA: Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism: Clinical and Experimental 1993; 42: 1443-1447.
50. De Boer H, Blok GJ, Voerman HJ, Phillips M, Schouten JA: Serum lipid levels in growth hormone-deficient men. J Clin Endocrinol Metab 1994; 43: 199-203.
51. Cuneo RC, Salomon F, Watts GF, Hesp R, Sonksen PH: Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency. J Clin Endocrinol Metab 1993; 42: 1519-1523.
52. Russell-Jones DL, Watts GF, Weissberger A, Naumova R, Myers J et al.: The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone-deficient patients. Clin Endocrinol 1994; 41: 345-350.
53. Johansson G, Oscarsson J, Rosen T, Wiklund O, Olsson G et al.: Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone-deficients adults. Influence of gender and Apo(a) and Apo(E) phenotypes. Arterioscler, Thromb Vasc Biol 1995; 15: 2142-2150.
54. Garry P, Collins P, Devlin JG: An open 36 month study of lipid changes with growth hormone in adults: lipid changes following replacement of growth hormone in adult acquired growth hormone deficiency. Eur J Endocrinol 1996; 134: 61-66.
55. Weaver JU, Monson JP, Noonan K, John WG, Edwards A et al.: The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity and cardiovascular risk factors in hypopituitary adults. J Clin Endocrinol Metab 1995; 80: 153-159.
56. Eden S, Wiklund O, Oscarsson J, Rosen T, Bengtsson BA: Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations. Arteriscler Thromb 1993; 13: 296-301.
57. Angelin B, Rudling M: Growth hormone and hepatic lipoprotein metabolism. Curr Opin Lipidol 1994; 5: 160-165.
58. Christ E, Cummings MH, Umpleby AM, Albany E, Wierzbicki A et al.: Very low density lipoprotein apolipoprotein B metabolism in adult growth hormone deficiency. J Clin Endocrinol Metab 1997; 4 (Suppl. A): 21.
59. Stabler B, Turner JR, Girdler SS, Light KC, Underwood LE: Reactivity to stress and psychological adjustment in adults with pituitary insufficiency. Clin Endocrinol 1992; 6: 467-473.
60. Rosen T, Wiren L, Wilhelmsen L, Wiklund I, Bengtsson BA: Decreased psychological well-being in adult patients with growth hormone deficiency. Clin Endocrinol 1994; 40: 111-116.
61. Burman P, Broman JE, Hetta J, Wiklund I, Erfurth EM et al.: Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial. J Clin Endocrinol Metab 1995; 80: 3585-3590.
62. McGauley GA: Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency. Acta Paediatr Scand 1989; 356 (Suppl.): 55-59.
63. Johansson JO, Larson G, Andersson M, Elmgren A, Hynsjo L et al.: Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitrers. Neuroendocrinology 1995; 61: 57-66.
64. Åström C, Pedersen SA, Lindholm J: The influence of growth hormone on sleep in adults with growth hormone deficiency. Clinical Endocrinology 1990; 33: 496-500.
65. Holmes SJ, Shalet SM: Which adults develop side effects of growth hormone replacement? Clin Endocrinol 1995; 43: 143-149.
66. Mårdh G, Lundin K, Borg G, Jonsson B, Lindeberg A: Growth hormone replacement therapy in adult hypopituitary patients with growth hormone deficiency: combined data from 12 European placebo-controlled trials. J Clin Endocrinol Metab 1994; 1 (Suppl. A), 43-49.
67. Malozowski S, Tanner LA, Wysowski D, Fleming GA: Growth hormone, insulin-like growth factor-I, and benign intracranial hypertension. N Engl J Med 1993; 329: 665-666.
68. Hoffman DM, Sullivan AJ, Baxter RC, Ho KK: Diagnosis of growth hormone deficiency in adults. Lancet 1994; 343: 1064-1068.
69. Rudman D, Kutner MH, Rogers CM, Lubin FM, Fleming GA et al.: Impaired growth hormone secretion in the adult population: relation to age and adiposity. J Clin Invest 1981; 67: 1361-1369.
70. Black MM, Shuster S, Bottoms E: Skin collagen and thickness in acromegaly and hypopituitarism. Clin Endocrinol 1972; 1: 259-263.
71. Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY et al.: Effects of human growth hormone in men over 60 years old. N Engl J Med 1990; 323: 1-6.